OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Publication Date
Release Date
2017
(4)
2025
(2)
2023
(1)
2018
(1)
2016
(1)
2015
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition.
Not available
S-EPMC5413401
|
biostudies-literature
Cite
Increasing the safety and efficacy of chimeric antigen receptor T cell therapy.
Not available
S-EPMC5546931
|
biostudies-literature
Cite
Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.
Not available
S-EPMC5563282
|
biostudies-literature
Cite
A functional unit combination strategy for enhancing red room-temperature phosphorescence.
Not available
S-EPMC10510757
|
biostudies-literature
Cite
Narrowing emission spectra based on indolocarbazole molecular model system: an experimental and theoretical study.
Not available
S-EPMC12572963
|
biostudies-literature
Cite
A comparative investigation on excimer fluorescence toward its bright future.
Not available
S-EPMC11744815
|
biostudies-literature
Cite
A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.
Not available
S-EPMC4800826
|
biostudies-literature
Cite
Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation.
Not available
S-EPMC5498341
|
biostudies-literature
Cite
Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor.
Not available
S-EPMC2982929
|
biostudies-literature
Cite
Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice.
Not available
S-EPMC4560113
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets